activities under this chapter related to the process for the review of device applications (as defined in section 379i(9) of this title); and

activities under this chapter related to human generic drug activities (as defined in section 379j–41 of this title).

with respect to the activities under subsection (b)(1), the goals referred to in section 379j–1(a)(1) of this title; and

with respect to the activities under subsection (b)(2), the goals referred to in section 379j–43(a) of this title.